Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Stefania Pipitone
Observed names:
Pipitone Stefania,
Pipitone, Stefania,
S. Pipitone,
S., Pipitone
Institutions:
University of Modena and Reggio Emilia,
Policlinico Umberto I,
Azienda Ospedaliero-Universitaria di Modena,
Sapienza University of Rome
Observed institutions:
University of Modena and Reggio Emilia,
Lund University,
Policlinico Umberto I,
Azienda Ospedaliero-Universitaria di Modena,
Sapienza University of Rome
ORCID:
0000-0003-2677-1877
Observed ORCID:
0000-0003-2677-1877
OpenAlex ID:
A5072846791
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours
2023
·
Ciro Celsa
, Giuseppe Cabibbo
, et al.
·
Journal of Hepatology
·
88
PDF
Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
2018
·
Claudia Omarini
, Giorgia Guaitoli
, et al.
·
Cancer Management and Research
·
80
PDF
Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications
2023
·
Cinzia Baldessari
, Stefania Pipitone
, et al.
·
Cancers
·
74
PDF
Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature
2019
·
Maria Giuseppa Vitale
, Cinzia Baldessari
, et al.
·
Clinical Genitourinary Cancer
·
35
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis
2023
·
Shobana Anpalakhan
, Alessio Signori
, et al.
·
iScience
·
31
PDF
De Novo Metastatic Prostate Cancer: Are We Moving toward a Personalized Treatment?
2023
·
Claudia Piombino
, Marco Oltrecolli
, et al.
·
Cancers
·
30
PDF
Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective Study
2020
·
Maria Giuseppa Vitale
, Stefania Pipitone
, et al.
·
Clinical Genitourinary Cancer
·
25
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study
2022
·
Sara Elena Rebuzzi
, Alessio Signori
, et al.
·
Journal of Translational Medicine
·
21
PDF
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab
2023
·
Martina Catalano
, Sara Elena Rebuzzi
, et al.
·
JAMA Network Open
·
20
PDF
Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies
2019
·
Angela Toss
, Marta Venturelli
, et al.
·
Cancers
·
20
PDF
Immunotherapy in urothelial cancer: current status and future directions
2023
·
Claudia Piombino
, Elena Tonni
, et al.
·
Expert Review of Anticancer Therapy
·
19
Homologous Recombination Repair Deficiency in Metastatic Prostate Cancer: New Therapeutic Opportunities
2024
·
Claudia Piombino
, Stefania Pipitone
, et al.
·
International Journal of Molecular Sciences
·
17
PDF
New Advances in Metastatic Urothelial Cancer: A Narrative Review on Recent Developments and Future Perspectives
2024
·
Elena Tonni
, Marco Oltrecolli
, et al.
·
International Journal of Molecular Sciences
·
15
PDF
Compassionate Use Program of Ipilimumab and Nivolumab in Intermediate or Poor Risk Metastatic Renal Cell Carcinoma: A Large Multicenter Italian Study
2022
·
Umberto Basso
, Federico Paolieri
, et al.
·
Cancers
·
15
PDF
Cerebellar metastasis of ovarian cancer: a case report
2023
·
Eleonora Cabitza
, Marta Pirola
, et al.
·
Journal of Medical Case Reports
·
12
PDF
Immunotherapy in the treatment of colorectal cancer: a new kid on the block
2018
·
Andrea Spallanzani
, Fabio Gelsomino
, et al.
·
Journal of Cancer Metastasis and Treatment
·
11
PDF
Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study
2024
·
Martina Catalano
, Sara Elena Rebuzzi
, et al.
·
Frontiers in Immunology
·
10
PDF
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study
2024
·
Roberto Iacovelli
, Chiara Ciccarese
, et al.
·
European Urology
·
10
Emerging antibodies for the treatment of pancreatic cancer
2017
·
Kalliopi Andrikou
, Chiara Peterle
, et al.
·
Expert Opinion on Emerging Drugs
·
9
Extravasation of enfortumab vedotin: a case report and literature review on antibody-drug conjugates
2025
·
Stefania Pipitone
, Maria Giuseppa Vitale
, et al.
·
European Journal of Hospital Pharmacy
·
6
Chasing the Role of miRNAs in RCC: From Free-Circulating to Extracellular-Vesicle-Derived Biomarkers
2023
·
Ilenia Mastrolia
, Virginia Catani
, et al.
·
Biology
·
6
PDF
Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer
2024
·
Elisa D'Agostino
, Luciana Mastrodomenico
, et al.
·
Cancer Treatment Reviews
·
5
Activity of cabozantinib (CABO) plus durvalumab (DURVA) in patients (pts) with advanced urothelial carcinoma (UC) or non-UC variant histologies (VH) after platinum chemotherapy: Interim results from the phase 2 ARCADIA trial.
2023
·
Patrizia Giannatempo
, Valentina Guadalupi
, et al.
·
Journal of Clinical Oncology
·
5
PDF
Exceptional response to lurbinectedin and irinotecan in BRCA -mutated platinum-resistant ovarian cancer patient: a case report
2022
·
Laura Cortesi
, Marta Venturelli
, et al.
·
Therapeutic Advances in Chronic Disease
·
5
Long survival of a young patient with Xp11.2 translocation metastatic clear cell renal carcinoma: case report
2021
·
Stefania Pipitone
, Maria Giuseppa Vitale
, et al.
·
Tumori Journal
·
5
Show more works
View as search
Works count:
56
Citation count:
593
H-index:
14
I10-index:
18
Year
Topic
Type